Literature DB >> 2257200

Cerebral ischemia in gerbils: postischemic administration of cyclohexyl adenosine and 8-sulfophenyl-theophylline.

D K von Lubitz1, P J Marangos.   

Abstract

Adenosine agonists have now been shown by several laboratories to have profound neuroprotective effects when administered either pre- or postischemia. In an effort to determine whether these effects are centrally mediated, the effects of the non-brain-permeable adenosine receptor antagonist 8-sulfophenyl-theophylline (8-SPTH) on cyclohexyladenosine (CHA) -mediated protection was determined. Both survival and neurologic outcome were assessed in gerbils following 30 minutes of bilateral carotid occlusion. A dose of 2 mg/kg of CHA 5 minutes postreperfusion resulted in highly significant increases in survival relative to saline injected controls. Administration of doses of 8-SPTH sufficient to normalize the hypotension observed with CHA resulted in the same degree of postischemic protection. Similar results were obtained when neurologic status was evaluated. The results indicate that the neuroprotective effects of CHA are apparently centrally mediated.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2257200     DOI: 10.1007/bf02896926

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  31 in total

Review 1.  Glutamate and the pathophysiology of hypoxic--ischemic brain damage.

Authors:  S M Rothman; J W Olney
Journal:  Ann Neurol       Date:  1986-02       Impact factor: 10.422

2.  The interdependency of cerebral functional and metabolic effects following massive doses of thiopental in the dog.

Authors:  J D Michenfelder
Journal:  Anesthesiology       Date:  1974-09       Impact factor: 7.892

Review 3.  The role of adenosine and its nucleotides in central synaptic transmission.

Authors:  J W Phillis; P H Wu
Journal:  Prog Neurobiol       Date:  1981       Impact factor: 11.685

4.  Synthesis of a stress protein following transient ischemia in the gerbil.

Authors:  T S Nowak
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

5.  The role of adenosine in the regulation of cerebral blood flow.

Authors:  H R Winn; G R Rubio; R M Berne
Journal:  J Cereb Blood Flow Metab       Date:  1981       Impact factor: 6.200

6.  Propentofylline (HWA 285) protects hippocampal neurons of Mongolian gerbils against ischemic damage in the presence of an adenosine antagonist.

Authors:  J DeLeo; P Schubert; G W Kreutzberg
Journal:  Neurosci Lett       Date:  1988-02-03       Impact factor: 3.046

Review 7.  Basic and clinical aspects of adenosinergic neuromodulation.

Authors:  P J Marangos; J P Boulenger
Journal:  Neurosci Biobehav Rev       Date:  1985       Impact factor: 8.989

8.  Cyclohexyl adenosine protects against neuronal death following ischemia in the CA1 region of gerbil hippocampus.

Authors:  D K von Lubitz; J M Dambrosia; O Kempski; D J Redmond
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

9.  Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.

Authors:  G Evoniuk; R W von Borstel; R J Wurtman
Journal:  J Pharmacol Exp Ther       Date:  1987-02       Impact factor: 4.030

10.  Regional glucose utilization and blood flow following graded forebrain ischemia in the rat: correlation with neuropathology.

Authors:  M D Ginsberg; D I Graham; R Busto
Journal:  Ann Neurol       Date:  1985-10       Impact factor: 10.422

View more
  11 in total

1.  Cerebral ischemia in gerbils: effects of acute and chronic treatment with adenosine A2A receptor agonist and antagonist.

Authors:  D K Von Lubitz; R C Lin; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1995-12-20       Impact factor: 4.432

2.  Dichloroacetate attenuates neuronal damage in a gerbil model of brain ischemia.

Authors:  R V Dimlich; P J Marangos
Journal:  J Mol Neurosci       Date:  1994       Impact factor: 3.444

3.  Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice.

Authors:  D K Von Lubitz; I A Paul; M Carter; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1993-11-16       Impact factor: 4.432

4.  Adenosine kinase is a new therapeutic target to prevent ischemic neuronal death.

Authors:  Detlev Boison; Hai-Ying Shen
Journal:  Open Drug Discov J       Date:  2010-01-01

5.  Penetration of adenosine antagonists into mouse brain as determined by ex vivo binding.

Authors:  J Baumgold; O Nikodijevic; K A Jacobson
Journal:  Biochem Pharmacol       Date:  1992-02-18       Impact factor: 5.858

Review 6.  Adenosine: a prototherapeutic concept in neurodegeneration.

Authors:  D K von Lubitz; M F Carter; M Beenhakker; R C Lin; K A Jacobson
Journal:  Ann N Y Acad Sci       Date:  1995-09-15       Impact factor: 5.691

7.  Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils.

Authors:  D K Von Lubitz; R C Lin; I A Paul; M Beenhakker; M Boyd; N Bischofberger; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1996-12-05       Impact factor: 4.432

8.  Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists.

Authors:  K A Jacobson; O Nikodijevic; X D Ji; D A Berkich; D Eveleth; R L Dean; K Hiramatsu; N F Kassell; P J van Galen; K S Lee
Journal:  J Med Chem       Date:  1992-10-30       Impact factor: 7.446

9.  Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.

Authors:  D K Von Lubitz; M Beenhakker; R C Lin; M F Carter; I A Paul; N Bischofberger; K A Jacobson
Journal:  Eur J Pharmacol       Date:  1996-04-29       Impact factor: 4.432

10.  Adenosine receptor prodrugs: synthesis and biological activity of derivatives of potent, A1-selective agonists.

Authors:  M C Maillard; O Nikodijević; K F LaNoue; D Berkich; X D Ji; R Bartus; K A Jacobson
Journal:  J Pharm Sci       Date:  1994-01       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.